Matches in SemOpenAlex for { <https://semopenalex.org/work/W103668124> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W103668124 abstract "(S)-Warfarin, the most active enantiomer of warfarin, is metabolized by CYP2C9. Genetic variations of the CYP2C9 gene result in slower metabolism and are major contributors to inter-patient dose variability with resultant INR instability, especially in patients on multiple medications. This leads to higher hemorrhagic and thrombotic complications. ATI-5923 (ARYx therapeutics Inc.) is a novel VKOR inhibitor that undergoes metabolism by human carboxyles-terase and not by CYP2C9. We hypothesize that time in therapeutic range (TTR) based on Rosendaal method is better for ATI-5923 than for historic warfarin and that maintenance dose is independent of CYP2C9 polymorphism, but dependent on VKOR haplotype. This was a multi-center, open-label, 3 month study of 66 patients with AF treated with ATI-5923. All except two patients were on prior warfarin. Periodic INR testing occurred twice weekly for the first 3 weeks and then weekly during the maintenance phase. Genetic testing for the CYP2C9 and VKORC1 polymorphism was performed on all patients. Drug dosing was performed using a standardized nomogram. Pre-study INRs and warfarin dose data were collected for up to one year prior to study entry. 77 % of patients were in therapeutic range (INR 2–3) after 7 days and 80% had stable INR (3 consecutive INR values within range without dose adjustment) by 3 months. For the maintenance phase the mean TTR was 71.5 and 59.3% for ATI-5923 and warfarin respectively (12.2% improvement; p=0.0009). Patients with the VKOR AA haplotype required lower maintenance doses than VKOR GA or GG haplotype (8.6 vs 15.8 and 18.7mg; p < 0.0001). CYP2C9 genotype had no influence on maintenance dose. CYP2C9 variants (n=20), showed a trend toward better control compared to warfarin; 16% improvement vs. 11% for wild type CYP2C9 (n =42). ATI-5923 has better INR control than prior warfarin therapy. VKOR AA patients require a significantly lower maintenance dose. CYP2C9 variants show a trend to added improvement compared to the CYP2C9 wild type, suggesting that, unlike warfarin, ATI-5923 is not influenced by CYP2C9 genetic variations." @default.
- W103668124 created "2016-06-24" @default.
- W103668124 creator A5009793881 @default.
- W103668124 creator A5023735102 @default.
- W103668124 creator A5026607998 @default.
- W103668124 creator A5029533765 @default.
- W103668124 creator A5061930952 @default.
- W103668124 creator A5063235551 @default.
- W103668124 date "2008-10-28" @default.
- W103668124 modified "2023-09-24" @default.
- W103668124 title "Abstract 4415: The Utility of Genotyping in the First Evaluation of a Novel Vitamin K Antagonist: ATI-5923" @default.
- W103668124 doi "https://doi.org/10.1161/circ.118.suppl_18.s_885-a" @default.
- W103668124 hasPublicationYear "2008" @default.
- W103668124 type Work @default.
- W103668124 sameAs 103668124 @default.
- W103668124 citedByCount "1" @default.
- W103668124 crossrefType "journal-article" @default.
- W103668124 hasAuthorship W103668124A5009793881 @default.
- W103668124 hasAuthorship W103668124A5023735102 @default.
- W103668124 hasAuthorship W103668124A5026607998 @default.
- W103668124 hasAuthorship W103668124A5029533765 @default.
- W103668124 hasAuthorship W103668124A5061930952 @default.
- W103668124 hasAuthorship W103668124A5063235551 @default.
- W103668124 hasConcept C104317684 @default.
- W103668124 hasConcept C126322002 @default.
- W103668124 hasConcept C135763542 @default.
- W103668124 hasConcept C19831878 @default.
- W103668124 hasConcept C2776301958 @default.
- W103668124 hasConcept C2776318485 @default.
- W103668124 hasConcept C2776704044 @default.
- W103668124 hasConcept C2776765323 @default.
- W103668124 hasConcept C2777288759 @default.
- W103668124 hasConcept C2779161974 @default.
- W103668124 hasConcept C2780035454 @default.
- W103668124 hasConcept C27924281 @default.
- W103668124 hasConcept C31467283 @default.
- W103668124 hasConcept C34626388 @default.
- W103668124 hasConcept C3946865 @default.
- W103668124 hasConcept C526171541 @default.
- W103668124 hasConcept C55493867 @default.
- W103668124 hasConcept C55775858 @default.
- W103668124 hasConcept C62231903 @default.
- W103668124 hasConcept C71924100 @default.
- W103668124 hasConcept C86803240 @default.
- W103668124 hasConcept C90924648 @default.
- W103668124 hasConcept C98274493 @default.
- W103668124 hasConceptScore W103668124C104317684 @default.
- W103668124 hasConceptScore W103668124C126322002 @default.
- W103668124 hasConceptScore W103668124C135763542 @default.
- W103668124 hasConceptScore W103668124C19831878 @default.
- W103668124 hasConceptScore W103668124C2776301958 @default.
- W103668124 hasConceptScore W103668124C2776318485 @default.
- W103668124 hasConceptScore W103668124C2776704044 @default.
- W103668124 hasConceptScore W103668124C2776765323 @default.
- W103668124 hasConceptScore W103668124C2777288759 @default.
- W103668124 hasConceptScore W103668124C2779161974 @default.
- W103668124 hasConceptScore W103668124C2780035454 @default.
- W103668124 hasConceptScore W103668124C27924281 @default.
- W103668124 hasConceptScore W103668124C31467283 @default.
- W103668124 hasConceptScore W103668124C34626388 @default.
- W103668124 hasConceptScore W103668124C3946865 @default.
- W103668124 hasConceptScore W103668124C526171541 @default.
- W103668124 hasConceptScore W103668124C55493867 @default.
- W103668124 hasConceptScore W103668124C55775858 @default.
- W103668124 hasConceptScore W103668124C62231903 @default.
- W103668124 hasConceptScore W103668124C71924100 @default.
- W103668124 hasConceptScore W103668124C86803240 @default.
- W103668124 hasConceptScore W103668124C90924648 @default.
- W103668124 hasConceptScore W103668124C98274493 @default.
- W103668124 hasIssue "suppl_18" @default.
- W103668124 hasLocation W1036681241 @default.
- W103668124 hasOpenAccess W103668124 @default.
- W103668124 hasPrimaryLocation W1036681241 @default.
- W103668124 hasRelatedWork W103668124 @default.
- W103668124 hasRelatedWork W1499157913 @default.
- W103668124 hasRelatedWork W2011570842 @default.
- W103668124 hasRelatedWork W2025668168 @default.
- W103668124 hasRelatedWork W2039577410 @default.
- W103668124 hasRelatedWork W2127265305 @default.
- W103668124 hasRelatedWork W2169552740 @default.
- W103668124 hasRelatedWork W2282667685 @default.
- W103668124 hasRelatedWork W2548537342 @default.
- W103668124 hasRelatedWork W2937586098 @default.
- W103668124 hasVolume "118" @default.
- W103668124 isParatext "false" @default.
- W103668124 isRetracted "false" @default.
- W103668124 magId "103668124" @default.
- W103668124 workType "article" @default.